|Bid||63.88 x 1400|
|Ask||63.89 x 800|
|Day's range||63.66 - 64.57|
|52-week range||61.28 - 77.91|
|PE ratio (TTM)||27.10|
|Earnings date||27 Jul 2018|
|Forward dividend & yield||1.68 (2.68%)|
|1y target est||71.85|
Colgate-Palmolive Co. said Monday afternoon that it would spend $5 billion to buy back shares, and the company's stock added 1% in after-hours trading. The $5 billion repurchase authorization replaces ...
As shown in the graph below, Colgate-Palmolive (CL) managed to improve its earnings in 2017, after witnessing weakness for a couple of years. Cost savings, a lower outstanding share count, and currency rates helped offset higher input costs, soft volumes, and lower net prices.
Colgate-Palmolive’s (CL) sales improved in the last reported quarter, thanks to its healthy performance in developed markets such as North America and Europe. However, growth slowed down in emerging markets, including Asia-Pacific, African-Eurasian, and Latin American regions.
Colgate-Palmolive (CL) has fallen this year, along with peers. Colgate-Palmolive stock had fallen 16.1% YTD (year-to-date) as of June 14, whereas Procter & Gamble (PG), Clorox (CLX), and Kimberly-Clark (KMB) had fallen 17.3%, 14.0%, and 15.4%, respectively.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Colgate, CME Group, Tesla and Lululemon
Investors need to pay close attention to Colgate-Palmolive (CL) stock based on the movements in the options market lately.
Today we’re going to take a look at the well-established Colgate-Palmolive Company (NYSE:CL). The company’s stock saw significant share price volatility over the past couple of months on the NYSE,Read More...
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kimberly-Clark (KMB) is showing improvement on both the sales and earnings fronts. However, near-term headwinds continue to restrict the company’s upside. Kimberly-Clark’s top line is benefiting from an improvement in its volumes and favorable currency rates. However, increased promotional spending to drive volumes is leading to lower net price realizations and, in turn, lower organic sales.
Colgate-Palmolive (CL) reported better-than-expected first-quarter earnings thanks to the lower effective tax rate. The company’s top line also improved on a YoY (year-over-year) basis, with strong volumes growth seen in North America. Favorable currency rates also supported its net sales growth.
Shares of household and personal care product manufacturers Procter & Gamble (PG), Clorox (CLX), Colgate-Palmolive (CL), and Kimberly-Clark (KMB) are underperforming the broader markets. Despite the fact that these companies have reported improvements in their volumes and earnings growth rates, investors don’t seem interested in giving them the benefit of the doubt.
The dividend yields of CPG (consumer packaged goods) manufacturers are inching up. For instance, Procter & Gamble (PG) and Kimberly-Clark (KMB) have current dividend yields of close to 4% based on their closing prices on May 15.
NEW YORK, May 08, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cboe ...
Clorox (CLX) continues to disappoint investors with its sluggish margin performance. The trend is likely to continue in the near term. Branded consumer packaged goods manufacturers in the United States are grappling with increased costs related to raw materials and packaging. Higher transportation costs, exacerbated by carrier supply restraints and driver shortages, are further pressuring profitability.
Coca-Cola (KO) announced its fiscal 1Q18 results on April 24. The revenue declined 16.5% to $7.6 billion and surpassed the estimates by ~4.0%. The company’s EPS increased 9.3% to $0.47 per share—compared to $0.43 in 1Q17. The EPS also surpassed the consensus estimate of $0.46. The stock fell 1.0% last week.
Numerous analysts covering Colgate-Palmolive (CL) stock decreased their target prices after the company’s 1Q18 results. Jefferies dropped its price target to $67 per share from $77, Wells Fargo reduced it to $68 from $73, and Berenberg lowered its target price to $67 from $69. The graph below shows the decline in analysts’ target prices for Colgate-Palmolive stock.
Colgate-Palmolive (CL) reported net sales of $4.0 billion, a shade lower than what analysts had expected but marking a 6.5% improvement YoY (year-over-year). Colgate-Palmolive’s top line benefited from currency rates boosting its sales growth rate by 4.5%. Volumes grew 2.0%, reflecting a 0.5% contribution from professional skin care acquisitions.
Colgate-Palmolive’s (CL) earnings finally came ahead of analysts’ expectation, after just meeting estimates in the past three quarters. Colgate-Palmolive’s 1Q18 adjusted EPS (earnings per share) of $0.74 exceeded analysts’ estimate of $0.72 and marked a 10.4% rise YoY (year-over-year).
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.